Guidelines Regarding Public Disclosure of Inventions. Internal disclosure of an Invention to the CVIP or Vice Chancellor for Research will not interfere with the ability to patent the Invention. However, Public Disclosure of an Invention prior to filing for a patent application (even one day before) will preclude the availability of patent protection in most countries. This legal rule applies to any non-confidential written or oral disclosure that describes the Invention (e.g., at a scientific meeting, in a journal, or even in an informal discussion with colleagues outside the University). Accordingly, the University strongly encourages Covered Individuals to disclose Inventions to the CVIP as soon as possible, and to delay Public Disclosure of the Invention until the evaluation process is completed and a patent application is filed. The CVIP and Vice Chancellor for Research will attempt to minimize delays in publication, but a delay of up to ninety days is often necessary for evaluation. The CVIP and Vice Chancellor for Research will make every effort to expedite the evaluation process when a Covered Individual indicates that there is a compelling need for rapid publication. During this interim period, an Invention may be safely disclosed outside of the University under the protection of a Confidential Disclosure Agreement ("CDA"), because disclosures made under an appropriate CDA are not considered Public Disclosures. The University therefore recommends that all Covered Individuals use the University-form CDA whenever they disclose information relating to an Invention while the Invention is under evaluation by the University, and the University strongly recommends use of the University-form CDA and consultation with the CVIP if a Covered Individual wishes to disclose an Invention to an Outside Researcher associated with a company or other for-profit organization, or directly to such an organization. The CVIP will make available appropriate forms of CDA. Faculty members have authority to sign the University-form CDA on behalf of the University when they will disclose information (but will not receive information), provided they send a fully signed original of the CDA to the CVIP as soon as possible. Alternatively, CVIP representatives are authorized to approve and sign CDAs on behalf of the University. Covered Individuals should be aware that Public Disclosure of an Invention prior to completion of the evaluation process and filing of a patent application will adversely affect the commercial value of the Inv...
Guidelines Regarding Public Disclosure of Inventions. Internal 22 disclosure of an Invention to the CVIP or Chief Research Officer 23 will not interfere with the ability to patent the Invention. However, 24 Public Disclosure of an Invention prior to filing for a patent 25 application (even one (1) day before) will preclude the availability 26 of patent protection in most countries. This rule applies to any non- 27 confidential written or oral disclosure that describes the Invention 28 (e.g., at a scientific meeting, in a journal, or even in an informal 29 discussion with colleagues). 30 31 Accordingly, the University strongly encourages Covered 32 Individuals to disclose Inventions to the CVIP as soon as possible, 33 and to delay Public Disclosure of the Invention until the evaluation 34 process is completed and a patent application is filed. The CVIP and 35 Chief Research Officer will attempt to minimize delays in 36 publication, but a delay of up to ninety (90) days is often necessary 37 for evaluation. The CVIP and Chief Research Officer will make 38 every effort to expedite the evaluation process when a Covered 39 Individual indicates that there is a compelling need for rapid 40 publication. 1 During this interim period, an Invention may be safely disclosed 2 outside of the University under the protection of a Confidential 3 Disclosure Agreement (“CDA”), because disclosures made under an 4 appropriate CDA are not considered Public Disclosures. The 5 University therefore recommends that all Covered Individuals use 6 the University-form CDA whenever they disclose information 7 relating to an Invention while the Invention is under evaluation by 8 the University, and the University strongly recommends use of the 9 University-form CDA and consultation with the CVIP if a Covered 10 Individual wishes to disclose an Invention to an Outside Researcher 11 associated with a company or other for-profit organization, or 12 directly to such an organization. The CVIP will make available 13 appropriate forms of CDA. Faculty members have authority to sign 14 the University-form CDA on behalf of the University when they will 15 disclose information (but will not receive information), provided 16 they send a fully signed original of the CDA to the CVIP as soon as 17 possible. Alternatively, CVIP representatives are authorized to 18 approve and sign CDAs on behalf of the University. 19 20 Covered Individuals should be aware that Public Disclosure of an 21 Invention prior to completion of the evaluation process and filing of
